State NV
Clinical Trials in Nevada
Recruiting clinical trials with at least one study location in Nevada. Data updated daily from ClinicalTrials.gov.
Top Conditions in Nevada
NCT05797831 Phase 2, Phase 3
Recruiting
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endo...
Condition
Endometrial Cancer
Enrollment
268 pts
Location
United States, Austria, Canada
Sponsor
Kartos Therapeutics, Inc.
NCT06972459 Phase 3
Recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight a...
Condition
Obesity
Enrollment
600 pts
Location
United States, Argentina, China
Sponsor
Eli Lilly and Company
NCT06679140 Phase 3
Recruiting
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolesc...
Condition
COVID-19 SARS-CoV-2 Infection
Enrollment
2,330 pts
Location
United States, Argentina, Belgium
Sponsor
Pfizer
NCT05894239 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Ph...
Condition
Metastatic Breast Cancer
Enrollment
230 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT07154823 N/A
Recruiting
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients ...
Condition
Acute Myeloid Leukaemia (AML)
Enrollment
550 pts
Location
United States
Sponsor
Tempus AI
NCT07104383 Phase 3
Recruiting
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Condition
Weight Loss
Enrollment
1,100 pts
Location
United States, Puerto Rico
Sponsor
Viking Therapeutics, Inc.
NCT06136650 Phase 3
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Age...
Condition
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Enrollment
1,314 pts
Location
United States, Australia, Brazil
Sponsor
Merck Sharp & Dohme LLC
NCT05966194 Phase 2
Recruiting
RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radia...
Condition
Oral Mucositis
Enrollment
216 pts
Location
United States
Sponsor
EpicentRx, Inc.
NCT05762107 Phase 2
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Condition
Type 1 Diabetes Mellitus With Hypoglycemia
Enrollment
186 pts
Location
United States, Canada
Sponsor
Zucara Therapeutics Inc.
NCT06662786 Phase 3
Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or ...
Condition
Colorectal Neoplasms
Enrollment
1,000 pts
Location
United States, Belgium, Brazil
Sponsor
Janssen Research & Development
NCT07096674 Phase 2
Recruiting
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopa...
Condition
Narcolepsy Type 1
Enrollment
90 pts
Location
United States
Sponsor
Centessa Pharmaceuticals (UK)
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06605183 N/A
Recruiting
10,000 Step Club: Community Walking Program for People with Parkinson's Disease
Condition
Parkinson Disease
Enrollment
60 pts
Location
United States
Sponsor
University of Nevada, Las Vega
NCT05566769 N/A
Recruiting
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMO...
Condition
Neuromyelitis Optica
Enrollment
103 pts
Location
United States, France, Germany
Sponsor
Ad scientiam
NCT07089888 Phase 3
Recruiting
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Condition
Tophaceous Gout
Enrollment
250 pts
Location
United States
Sponsor
Crystalys Therapeutics
NCT06703073 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
600 pts
Location
United States
Sponsor
PPD Development, LP
NCT05040360 Phase 2
Recruiting
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendo...
Condition
Metastatic Malignant Neoplasm in the Liver
Enrollment
141 pts
Location
United States, Mexico, Uruguay
Sponsor
SWOG Cancer Research Network
NCT06079879 Phase 3
Recruiting
A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BA...
Condition
Essential Thrombocythemia
Enrollment
340 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05633654 Phase 3
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physic...
Condition
Triple Negative Breast Cancer
Enrollment
1,514 pts
Location
United States, Australia, France
Sponsor
Gilead Sciences
NCT06584357 N/A
Recruiting
Development of a Database to Investigate Digital and Blood-Based Biomarkers and ...
Condition
Mild Cognitive Impairment
Enrollment
1,200 pts
Location
United States, Canada, United Kingdom
Sponsor
GAP Innovations, PBC
NCT03695978 N/A
Recruiting
Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untre...
Condition
Haemophilia A
Enrollment
200 pts
Location
United States, Argentina, Azerbaijan
Sponsor
Octapharma
NCT07298330 Phase 3
Recruiting
A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic ...
Condition
Chronic Hepatitis D Infection
Enrollment
80 pts
Location
United States, Belgium, Bulgaria
Sponsor
Mirum Pharmaceuticals, Inc.
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT06389136 Phase 3
Recruiting
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Der...
Condition
Atopic Dermatitis
Enrollment
200 pts
Location
United States, Canada, Colombia
Sponsor
AbbVie
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals